MediWound, an Israeli developer of products to treat burns and wounds using non-surgical tissue repair, said on Wednesday it ...

MediWound has commenced a pivotal, multicentre Phase III VALUE trial to assess its bioactive debridement therapy, EscharEx, ...

On-demand video webcast now available here IRVINE, CA / ACCESS Newswire / February 19, 2025 /enVVeno Medical Corporation ...

One-year follow-up data demonstrates sustained improvements across venous specific quality-of-life (QoL) indicators.

On-demand video webcast now available here IRVINE, CA / ACCESS Newswire / February 19, 2025 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of ...

Venous leg ulcers affect about 2% of individuals aged 65 and older, with over 1.5 million new cases reported annually in the U.S., the company said. They typically develop on the lower extremities ...

Take steps to improve blood flow to legs and help prevent venous conditions such as varicose and spider veins. Suggestions ...

Skin Integrity Team has been shortlisted in three categories at this year’s Journal of Wound Care Awards, which take place ...

Tactile Systems Technology (NASDAQ:TCMD – Get Free Report) is projected to release its earnings data after the market closes on Tuesday, February 18th. Analysts expect Tactile Systems Technology to ...

MANSFIELD –  Hospital is proud to announce its 100th placenta donation through Lifeline of Ohio’s Placenta Donation Program.

MediWound (NASDAQ:MDWD) stock climbed 4% following news that the company has initiated a Phase 3 study of its wound care product EscharEX in the treatment of venous leg ulcers, or VLU. The company ...